Contact Us    |      Join    |

"The Voice of Oncology in Massachusetts"

Access and Reimbursement Assistance

A compilation of pharmaceutical patient assistance programs, along with the necessary contact details for reimbursement purposes. Additionally, we have compiled a list of several co-pay assistance programs that you may find helpful.


AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients. Our Patient Assistance Programs are intended for people that live in the United States, have limited or no health insurance coverage and demonstrate qualifying financial need. 

If you have any questions, visit the FAQs or call us at 1-800-222-6885.

Program Info:  myAbbVie Assist


Amgen Assist 360™ is a single place for patients, caregivers, and healthcare professionals to go to find the support, tools, and resources most important to them. 

Call 1-888-4ASSIST (1-888-427-7478)

Program Info:  amgenassist360


Astellas Pharma Support Solutions offers access and reimbursement support to help patients overcome challenges to accessing Astellas products. Reimbursement Hotline is Toll-free: 1(800) 477-6472

Program Info:  Astellas Pharma Support Solutions

As a part of our commitment to providing support to healthcare professionals and patients, we’ve developed resources for various stages of patient care. Visit the Astellas Resource Portal.

Reimbursement Contact:

Kevin Kobylinski, Access and Reimbursement Manager
C: 603-502-8175

Drugs: PADCEV™ (enfortumab vedotin-ejfv), Xospata® (gilteritinib), Xtandi® (enzalutamide)


At AstraZeneca, we believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. It’s why we’ve offered patient assistance programs for over 30 years.  The program provides personal support to help streamline access and reimbursement for select AstraZeneca medicines.

Access 360 provides:  

  • Assistance with understanding patient insurance coverage and pharmacy options
  • Prior authorization support
  • Claims and appeal process support
  • Resources for patients

Program Info: AstraZeneca Access 360

The AstraZeneca AZ&ME Prescription Savings Program is helping patients who are having trouble affording their AstraZeneca medicines. This site will guide you through the AZ&ME application process to see if you are eligible for the program. Contact: 1-800-AZandME

Program Info: AZ&ME

AVEO Oncology

The AVEO ACE Access Center of Excellence is a comprehensive program dedicated to providing personalized support to patients and their loved ones throughout the FOTIVDA treatment journey

Contact: 1-833-FOTIVDA (1-833-368-4832)

Program Info:  AVEO ACE


Visit the website to learn more about Blueprint Medicine’s patient support program, YourBlueprint. This website provides information about access and reimbursement, financial assistance, how to order your patient’s prescribed drug, and helpful resources.

Unbranded/Disease Awareness:

Program Info: YourBlueprint

Reimbursement Contact:

Fred Richards, Associate Director, Regional Marketing, New England and New York

Blueprint Medicines


Cell: 781-258-1457


  • Ayvakit (avapritinib) Indicated for: Systemic Mastocytosis (Indolent SM, Smoldering SM, Advanced SM, SM with AHN), and PDGFRA GIST.
  • Gavreto (pralsetinib) – Indicated for: RET+ mNSCLC and RET+ advanced or metastatic thyroid carcinoma.

Bristol-Myers Squibb

Bristol-Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement services. Contact: 1-800-861-0048

Program Info:  BMS Access Support

Daiichi Sankyo, Inc.

Access Central is committed to helping you get the Daiichi Sankyo medication you need and is an important resource for you and your doctor. We provide support tailored to your unique needs, including:

  • Help getting the medication you need by working with your insurance company
  • Financial assistance programs for eligible people with and without insurance
  • Assistance with understanding your insurance coverage

Contact: 1-866- 4-DSI-NOW (1-866-437-4669)



At Eisai, everything we do is guided by a simple principle: patients and their families come first and we have a responsibility to listen to and learn from them. We call this human health care, or hhc.

Benefits investigation, Financial assistance, Eisai Patient Support Program Hotline, Appeal Information, and Prior Authorization Information

Program Info: Patient Support for HCPs|LENVIMA (lenvatinib) Reimbursement (

Eisai Assistance Program: For program and eligibility information, and to review the program terms and conditions, please visit or call 1-866-61-EISAI (1-866-613-4724).

Reimbursement Contact:

Niya Prabhu, Sr Manager, Access & Reimbursement


Phone: 917.232.5956

Drugs: Lenvima and Halaven


Exelixis Access Services (EASE). Access. Assistance. Along The Journey.

Exelixis Access Services® (EASE) provides a variety of support to help your patients start treatment quickly. EASE can help meet the unique needs of your patients and practice at each step along the access journey.

Contact: 1-844-900-EASE (3273)

Program Info:


Genentech is dedicated to helping patients. Since Genentech started providing access and reimbursement support almost 20 years ago, Genentech has helped more than 2 million patients access the medicines they need. 

Contact: 855-MYCOPAY (855-692-6729)

Patient Assistance Programs via Genentech Access Solutions include:

Genentech BioOncology Co-Pay Card - The Genentech BioOncology Co-Pay Card is for commercially insured patients receiving treatment with a Genentech BioOncology product that meet certain eligibility criteria. 

    Co-Pay Assistance Foundations - If privately or publicly insured patients have difficulty paying their co-pay, co-insurance or other expenses, Genentech Access Solutions can refer them to a co-pay assistance foundation supporting their disease.

      Genentech Patient Foundation - The Genentech Patient Foundation was established to help patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and who meet specific criteria to receive their prescription free of charge.

      Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab)

      Oral Products: ALECENSA® (alectinib), COTELLIC® (cobimetinib), ERIVEDGE® (vismodegib),GAVRETO (pralsetinib),ROZLYTREK® (entrectinib), TARCEVA® (erlotinib), VENCLEXTA™ (venetoclax) ZELBORAF® (vemurafenib)

      Subcutaneous Products: ​HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), ​PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human)


      TRODELVY ACCESS SUPPORT is a patient access and reimbursement support program. 

      Please click to see full Prescribing Information, including BOXED WARNING.

      Program Info:


      Together with GSK Oncology. At GSK, we understand that a cancer diagnosis can be overwhelming for patients and loved ones. Treatment considerations and costs can add undue stress, especially if you’re unsure what coverage options are available or how to access them. Together with GSK Oncology is here to help, offering patients and healthcare professionals a variety of access and reimbursement services for all GSK oncology products—all in one place.

      Program Info:


      Visit the website for more information on Incyte's Patient Support Programs.

      Program Info:


      Jakafi (ruxolitinib), Pemazyre (pemigatinib), Zynyz (retifanlimab-dlwr)

      Janssen Oncology

      Janssen Compass is a new patient offering with a single point of contact for your patients, helping to clarify their path by providing information, education, and helping them become better advocates for themselves. Janssen Compass Program Overview.

      Compass Info:

      Janssen Care Path: For assistance regarding Darzalex (daratumumab), Yondelis (trabectedin), Zytiga (abiraterone acetate), Doxil (doxorubicin HCI liposome injection), Procrit (epoetin alfa), and Sylvant (siltuximab) 

      Care Path Info:

      Janssen advocacy organizations offer a range of different services, including financial support or transportation services. They may even be able to help you in ways you never expected. Use this tool to find organizations near you that can help.  

      Janssen's Advocacy Connector:

      Jazz Pharmaceuticals

      JazzCares provides access and reimbursement support to Jazz medications. See the downloadable handout for information. 

      Contact: 1-833-533-JAZZ (5299)

      Program Info:

      Karyopharm Therapeutics

      KaryForward can assist with access and insurance coverage, financial assistance, and nurse care manager support.  KaryForward is here to help you every step of the way — from insurance coverage and financial assistance to support and resources — so you can focus on moving forward with your life.

      1-877-KARY4WD (1-877-527-9493)

      Program Info:

      Reimbursement Contact:

      Jacqueline Buckley, Corporate Account Director
      85 Wells Avenue Suite 210, Newton MA 02459
      Cell: 774-236-0231

      Drugs: XPOVIO® (selinexor)

      Lilly Oncology

      Lilly is dedicated to developing treatments, but we're more than just our medicines. We’re determined to do our part to help patients and their loved ones. Through the Lilly Oncology Support Center, we strive to offer personalized treatment support for eligible patients prescribed a Lilly Oncology product. 1-866-472-8663

      Program Info:  Lilly Oncology Support Center

      Lilly Cares® Foundation Patient Assistance Program. Helping patients with financial need receive their prescribed Eli Lilly and Company (Lilly) medications at no cost. 1-800-545-6962

      Lilly Cares Info:

      Drugs: Cyramza (ramucirumab), Alimta (pemetrexed), Erbitux (cetuximab),Retevmo (Selpercatinib), Verzenio (abemaciclib), Portrazza (necitumumab)


      The Merck Access Program is here to help answer your questions about insurance and coverage after you have been prescribed KEYTRUDA by your healthcare provider. The Merck Access Program provides information and resources that you may find helpful. 1-855-257-3932

      Program Info:

      Patient Support: The KEY+YOU program is designed for patients prescribed KEYTRUDA (pembrolizumab) for an approved indication. Educational resources are provided to patients and caregivers to help you understand your treatment with KEYTRUDA (pembrolizumab) and be more active and vocal in your or your loved one’s care.

      Program Info: KEY+YOU

      Reimbursement Contact:

      Mark Montello, Medicare Account Executive

      Phone: 603-321-1145


      Novartis Oncology Universal Co-pay Program:

      Novartis HCP Info:

      Reimbursement Contact:

      Elizabeth Gugliotta, Associate Director Access & Reimbursement


      Cell: 401-480-9905


      The Pfizer Patient Assistance Program (PAP) provides free medicines to eligible patients in need.

      PAP Program Info:

      Pfizer RxPathways connects eligible patients to assistance programs that offer insurance support, co-pay assistance, and medicines for free or at a saving. 

      Drugs: Besponsa, Bosulif, Braftovi, Daurismo, Ibrance, Inlyta, Lorbrena, Mektovi, Mylotarg, Retacrit, Talzenna, Vizimpro, Xalkori

      Pfizer RxPathways Info: Visit or call the toll-free phone number 1-844-989-PATH (7284) to consult with a Pfizer Medicine Access Counselor.

      Pfizer Oncology TogetherTM, we treat your individual needs as a priority. We’ll help you identify financial assistance options so you can get your prescribed TRAZIMERA. We can also connect you with a dedicated Care Champion who has social work experience and will offer resources that may help with some of your day-to-day challenges

      Pfizer Oncology Together Info:

      Reimbursement contact:

      Julie Rogers, MBA, CRT, CPC, Field Reimbursement Manager

      Phone: 860-422-0420

      PHARMACYCLICS LLC, an AbbVie company

      By Your Side* is a patient program designed specifically to support IMBRUVICA® (ibrutinib) prescribed patients. Prescribing Information:

      Program Info: By Your Side


      LIBTAYO Surround Patient Support Program can help patients access LIBTAYO® (cemiplimab-rwlc) and navigate the health insurance process. It provides:

      • Access and reimbursement support, including benefits investigation, prior authorization, and claims assistance
      • Financial support, including the Patient Assistance Program and Commercial Copay Program
      • Additional support through dedicated Patient Navigators, including appointment reminders, local support groups, transportation services, and educational resources

      For more information, call LIBTAYO Surround at 1.877.LIBTAYO (1.877.542.8296) Option 1, Monday–Friday 8:00 AM–8:00 PM Eastern time.

      Program Info: LIBTAYO Surround


      RIGEL ONECARE is a patient support center whose nurse navigators provide support for patients prescribed TAVALISSE (fostamatinib disodium hexahydrate) tablets.

      Contact RIGEL ONECARE at 833-744-3562 for more information about specific programs.  Patient Assistance Program Form.

      Program Info:  RIGEL ONCECARE

      TAVALISSE TOGETHER is a program for adult patients with chronic immune thrombocytopenia (ITP) who are taking or are interested in taking TAVALISSE. This program partners with patients throughout their treatment journey, helping them to become successful with their ITP treatment and achieve their goals.

      Program Info:


      CareASSIST® Helping eligible patients access their prescribed medications.

      Program Info:

      Reimbursement Contact:

      Mike Brooks, Regional Account Manager
      Phone: 484-686-9380

      Drugs: Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase)

      Seagen is your all-in-one resource for help with the cost of treatment, determining insurance coverage, one-on-one support, and access to additional resources and educational tools.  Email:

      Program Information:


      ServierONE is your all-in-one resource for help with the cost of treatment, determining insurance coverage, one-on-one support, and access to additional resources and educational tools. 

      Email or call 1-844-409-1141 (Tibsovo); 1-800-813-5905 (all other products).

      Program Information:

      Menarini Stemline

      Stemline ARC® provides access support, reimbursement assistance and educational resources to help patients and the healthcare professionals involved in their care, so patients can focus on what matters most—their health. Connect with a Stemline ARC Patient Advocate at 1-833-4-STEMLINE (1-833-478-3654), 9:00 AM to 6:00 PM ET, Monday through Friday, to learn more.

      Program information:

      Drugs: ORSERDU (elacestrant); ELZONRIS (tagraxofusp-erzs)

      Takeda Oncology

      Takeda Oncology Here2Assist is a comprehensive support program committed to helping patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their Takeda Oncology treatment. 

      Program Info:

      Reimbursement Contact: 

      Deborah Looney, Field Access Director
      Phone: 617-543-9736

      Co-Pay Assistance

      ACCC Patient Assistance and Reimbursement Guide is available online and in print FREE to ACCC members. Expanded and updated, ACCC's Patient Assistance and Reimbursement Guide features a quick reference guide by drug name with links directly to the drug manufacturers. 

      The CancerCare Co-Payment Assistance Foundation is a not-for-profit organization established in 2007 to address the needs of individuals who cannot afford their insurance co-payments to cover the cost of medications for treating cancer. 

      Family Reach is a national nonprofit dedicated to alleviating the financial burden of cancer. Working with more than 400 top-tier hospitals and cancer centers nationwide, they provide immediate financial assistance, education and navigation to families before they hit critical breaking points. 

      They created the Medicine Assistance Tool (MAT) to provide a dedicated search engine that allows users to search for financial assistance resources available to them, their loved ones or patients in their lives through the various biopharmaceutical industry programs available for patients who are eligible.

      The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications.

      The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance. Call counselors personally guiding patients through the enrollment process.

      PSI is the "ground breaking" 501(c)(3) non-profit, charitable organization helping people who live with certain chronic illnesses or conditions locate suitable health insurance coverage and access ways to satisfy expensive co-payments.  PSI provides assistance with the cost of health insurance premiums associated with COBRAs, State High Risk Pools, Open enrollment,  Guaranteed Issue policies, HIPAA conversion policies; and prescriptions co-payments associated with private insurance as well as with Medicare Parts B and D.


      860 Winter Street, Waltham, MA, 02451


      tel: 781.434.7329

      Massachusetts Society of Clinical Oncologists ©2024

      Powered by Wild Apricot Membership Software